You are here
The NIH Office of Science Policy (OSP) promotes progress in the biomedical research enterprise through the development of sound and comprehensive policies. OSP also is the primary policy adviser to the NIH Director on matters of significance to the agency, the research community, and the public. OSP works on a wide range of issues including biosafety, biosecurity, genetic testing, genomic data sharing, human subjects protections, the organization and management of the NIH, and the outputs and value of NIH-funded research. This is accomplished through a wide range of analyses and reports, commentary on emerging policy proposals, and the development of policy proposals for consideration by NIH, the Federal government, and the public.
The Office of Legislative Policy and Analysis (OLPA) serves as the principal office within the Office of the Director (OD), National Institutes of Health (NIH), for providing legislative analysis, policy development, and liaison with the Congress. OLPA facilitates and enhances the relationship between NIH and the Congress; advances NIH legislative priorities; and ensures that the NIH community receives essential information, advice, and guidance regarding developments in the Congress that affect NIH.
This page last reviewed on February 1, 2018